MDM2 and hepatocellular carcinoma: URI promotes the ubiquitination and degradation of p53 in a TRIM28-MDM2-dependent manner. p53 binds to the promoter of SCD1 and inhibits its transcription, thereby mediating lipid metabolism reprogramming that confers resistance to TKI-induced ferroptosis in hepatocellular carcinoma.